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THE BIOETHICS MOVEMENT AND HOSPITAL
ETHICS COMMITrEES
JOHN C. FLETCHER, PH.D.*
INTRODUCTION
This Article responds to Susan Wolf's analysis of the strengths
and weaknesses of hospital ethics committees. Her argument is
that a kind of identity crisis exists among these rapidly proliferating
groups.' When decisionmakers in very hard cases ask for their help,
are these committees advisory only or do they exist to adjudicate
and protect patients' interests?2 Wolf argues the latter case, and she
finds little evidence of ethically sound due process procedures for
case review in the vast majority of committees.' I agree with her
major argument that ethics committees exist to protect patients and
to be a force to work for the best outcome in cases where the pa-
tient's best interests are in dispute. This argument is consistent with
the purpose of clinical ethics.4
* Ph.D., Professor of Biomedical Ethics and Religious Studies, University of Vir-
ginia. Director, University of Virginia Center for Biomedical Ethics.
1. See Wolf, Ethics Committees and Due Process: Nesting Rights in a Community of Caring,
50 MD. L. REV. 798, 805, 820-22 (1991).
2. See id. at 814-20.
3. See id. at 802-03.
4. "Clinical ethics" is an interdisciplinary activity to identify, analyze, and resolve
ethical problems that arise in the care of particular patients. The major thrust of clinical
ethics is to work for outcomes that best serve the interests and welfare of patients and
their families. This activity is related conceptually to biomedical ethics, a broader, inter-
disciplinary branch of ethics that has evolved in the last twenty years to study ethical,
legal, and social issues raised in the life sciences, including medicine.
My own tendency is to encourage "realism" in clinical ethics. Realism is intended
in the usual meaning of "Be a realist," that is, be concerned to get the facts of the
problem or case straight; to ascertain the patient's preferences; to identify the ethical
problems in the context of the case; to weigh the merits of competing arguments and
sets of interests against standards that arise from practical experience; and, in the most
complex cases, to be able to accept a rough approximation of an ideal resolution after
evaluating all of the real options-that is, realists are willing to compromise.
Realism in ethics is wary of positions that are impracticable or overly theoretical,
visionary, and sentimental. Moral conflicts are conflicts of desires, interests, and princi-
ples. These conflicts are very hard to unravel and understand. The purpose of theory in
clinical ethics is to deepen and strengthen the understanding of such conflicts, but not to
dominate or overwhelm the decisionmaking process. The most elemental purpose of
morality itself is to protect human beings and other species from harm. The basic pur-
pose of ethics (not morality, which is better understood as a kind of institution within
institutions) is to protect human beings, societies, and other species from the harms that
follow when real moral conflicts are avoided or obscured. Ethics is reflection that in-
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Identity crises or confusion about what roles are appropriate
for ethics committees to play can be minimized if one understands
the functions performed by such committees in the past and those
to be carried out in the future. My response to Wolf begins in Part
II with a historical perspective on the "bioethics" movement, its ma-
jor concerns, and the enduring institutional expressions of these
concerns. It then moves in Part III to an agenda for national and
regional action. Strategies to start or strengthen ethics committees
in health care institutions have a high priority within this larger
agenda. One strategy is to strengthen the committee by defining its
place of pre-eminence within an institutional ethics program that also
serves the community. Although most ethics committees in hospi-
tals or nursing homes are isolated, unrecognized, and unrelated to
clinical and other crucial activities, this situation can be changed by
systematic intervention and hard work. Three other major issues on
the agenda are also discussed. Hopefully, this Article will illuminate
more clearly the role and future of hospital ethics committees.
Wolf's diagnosis of the "identity crisis," which involves a con-
flict between the ethics committee's roles as "consultation model"
and "adjudicatory model,"5 can almost always be resolved in favor
of patient interests if the ethics committee has won the strong sup-
port of leaders in the institution and in the community. Wolf is cor-
rect that the committee's role must include case reviews with
procedures that adequately protect the patient's due process rights.6
However, serious committee review of cases, in either the adjudica-
tory or conflict resolution model ought only to occur after prior eth-
volves the whole person in moral problems, and in the evaluation of the fitness for sur-
vival and evolution of the moralities required by societies. Avoiding real analysis of
moral conflicts allows the basic causes of these special disputes to grow, to obscure legit-
imate claims, and to drown these claims with moralism. Moralism is the language of
avoidance of the honest labors of ethics. The first task of ethics is to provide insight into
everyday moral problems and the fitness of the moral guidance societies make for them-
selves and their members. This task must be undertaken in special settings, like the
clinical setting, and must include the persons most involved--clinicians and their pa-
tients.
For this reason, one must be wary of the term "ethicist" to describe what any one
person does in the clinical setting. Clinical ethics is a group activity, and contributions
are made to it from the disciplines of medicine, nursing, law, theology and religious
studies, philosophy, the social and behavioral sciences, and others. Ethics is the busi-
ness of everyone concerned with the welfare of the patient, not just those with special
training in the history and methodology of ethical reasoning. The role of those who
specialize in nurturing the activity of clinical ethics is better understood as that of a
"consultant in clinical ethics," than of an "ethicist." This term avoids the implication of
elitism or domination of the process of clinical ethics.
5. See Wolf, supra note 1, at 814.
6. See id. at 847-52.
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ics consultation efforts that involve the patient, family, and others
have been inadequate to assist decisionmakers in resolving the ethi-
cal problem. Ethics consultation at the bedside can be done by an
ethics committee subgroup specializing in such encounters, or by a
consultation service accountable to the committee. In most cases,
this timely and personal service will be sufficient to assist the person
most involved in the case to identify, think through, and attempt to
resolve the ethical problems in the case. Thus, optimally the ethics
committee case review is a second-tier of conflict resolution that oc-
curs after prior ethics consultation, provided on behalf of the com-
mittee, has proven insufficient to resolve conflict.7
Resolution of ethical issues in clinical settings will always re-
main a volatile area. The basic tensions in competing ethical posi-
tions and arguments for divergent options that arise in the care of
particular patients cannot be avoided. Even when the utmost care is
employed during consultations and committee deliberations, those
who give advice on clinical-ethical problems approach these issues
from a variety of perspectives, and their suggestions and counsel
will continue to fuel heated debate. Although there is rarely one
correct way to resolve an ethical dilemma, the committee must reach
a conclusion based on what members believe is the best possible
outcome. And to make a decision means to cut off options. De-
pending upon the nature of the case, some options and the values
and principles that underlie them must be forsaken. Grief over the
loss of valued options in a contested decision is as real as grief over
the loss of any other real entity or person. Ethics alone cannot ad-
dress the loss of values and the finiteness of human existence. Eth-
ics does not subsume the meaning or purpose of human existence.
T.S. Eliot may have had this reality in mind when he wrote these
lines:
Footfalls echo in the memory
Down the passage which we did not take
Towards the door we never opened
Into the rosegarden. s
I. BIOETHICS AS A PLURALISTIC MOVEMENT
Bioethics was a child of the 1960s, a time of turmoil, rapid in-
ternational cultural change and revolutionary zeal. The rapidity and
7. See Povar, Evaluating Ethics Committees: What Do We Mean By Success?, 50 MD. L.
REV. 904, 915-16 (1991).
8. Eliot, Burnt Norton, in T.S. ELIOT COLLECTED POEMS 1909-1962 175 (1963).
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dilemmas of cultural change, were captured in Margaret Mead's fa-
mous line that "everyone born and bred before World War II is an
immigrant in time."9 Although bioethics drew some intellectual re-
sources from the ancient discipline of medical ethics, its major
themes have their roots in the 1960s movements for civil rights, wo-
men's rights, and consumer interests. American culture, its institu-
tions, its chronic racism, and the morality of the Vietnam War were
under radical criticism and reform. My characterization of bioethics
as a pluralistic movement fits in part with the analysis of Ren6e Fox,
an astute social chronicler of bioethics in the United States, who de-
scribes this period and its "manifestations of bioethical concern."'"
The pluralism of thought within the bioethics movement perhaps is
not always apparent to Fox. When describing a social movement,
however, one has considerable latitude. It is broad enough to in-
clude conservative and liberal religious thinkers as well as those-
like myself-who seek significant reform of national, regional, and
local health care patterns. Fox tends to view bioethics as dominated
by analytical philosophers who reinforce individualism and lack ap-
preciation for the social context of ethical problems in health care."
If the bioethics movement today includes all of those who labor in
the areas of research ethics, patient care ethics, American health
care reform, religion and philosophy, then "pluralism" is a fitting
term.
Social movements depend upon, interact with, and react to
political movements. One can better understand bioethics-in its
local, regional, and national expressions-as a pluralistic movement
responding in part to national political movements. Today, local
and regional interests in bioethics are stronger, in part because of
the politics of the 1980s, which were marked by a resurgence of
"American and family values" and regional, local, and special inter-
ests. Such special values cut towards special interests and regional-
ism. The politics of the 1960s and 1970s, despite its turmoil and
conflict, was more focused on structural values-like respect for
persons, justice, and equality-that cut towards sets of more general
9. In 1970, Margaret Mead described the character of the era in which bioethics was
born: "all ... are equally immigrants into the new era-some come as refugees and
some as castaways . . . everyone born and bred before World War II is ... an immigrant
in time ... struggling to grapple with the unfamiliar conditions of life in a new era." M.
MEAD, CULTURE AND COMMITMENT 72 (1970).
10. R. Fox, Advanced Medical Technology-Social and Ethical Implications, in EsSAYS IN
MEDICAL SOCIOLOGY 413 (1979).
11. See Fox & Swazey, Medical Morality Is Not Bioethics-Medical Ethics in China and the
United States, 27 PERSP. BIOLOGY & MED. 336, 354 (1984).
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interests and the renewal of national institutions and liberal democ-
racy. Renewal of national institutions that belong to all the
people-the branches of national and state government, public
health, public education, public welfare, and public safety-has
been muted, even abandoned in the 1980s, as these structural val-
ues were muted. The 1980s also saw nationally elected officials
withdraw from active support of an enduring national forum in
which to debate and consider bioethical issues.' 2 The avoidance of
ethical labors at the national level-and its replacement by moralism
and bureaucratic fiats-is especially apparent in the lack of coherent
public policy on research activities involving the human embryo, fe-
tus, and fetal tissue transplants. The need for a national forum for
civil bioethics debate of these issues and the restoration of the free-
dom of scientific inquiry at the federal level must be on the bioethics
agenda. Cessation of disciplined debate and suppression of re-
search in these areas harm the quality of ethical and scientific con-
siderations in the whole body politic. Whenever scientific research
and ethical debate is stifled on the national level, it also endangers
the freedom of research and information on the local level. Local
and regional bioethics groups, including ethics committees in health
care institutions, can study these two issues and express their con-
cerns to elected and appointed officials.
A. The Objective of Bioethics
The role of ethics committees in health care can be understood,
in part, by viewing them as one outcome of an older movement of
social forces arrayed to implement the objective of "bioethics."' 3
Bioethics is not strictly an academic discipline in the traditional
sense, as ethics is a branch of philosophy or religious studies. It is
true that bioethics is being studied in many interdisciplinary pro-
grams. Real changes in curricula and faculty assignments have oc-
curred in the name of bioethics. The scholarly literature in
bioethics is enormous and still growing rapidly.' 4 A second edition
12. See infra subpart III(c).
13. Van Rensselaer Potter was probably the author of the term "bioethics," but his
claim to have given birth to a field that is supposed to accompany the term is hard to
support. Potter, Bioethics: The Science of Surival, 14 PERSP. BIOLOGY & MED. 127 (1970).
See Fox, supra note 10, at 413 n.l. In my view, Joseph Fletcher's book, Morals and
Medicine, was the most important early written work in the post-World War II examina-
tion of medical ethics and the physician-patient relationship. It appeared just before the
rise of concern about research ethics and the explosion of knowledge in the life sciences
in the 1960s. SeeJ. FLETCHER, MORALS AND MEDICINE (1954).
14. The largest collection is housed in the National Reference Center for Bioethics
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of an Encyclopedia of Bioethics is now underway. The first edition, pub-
lished in 1978, took five years to produce and publish.' 5 It defined
bioethics as "the systematic study of human conduct in the area of
the life sciences and health care, insofar as this conduct is examined
in the light of moral values and principles."' 6 This definition, how-
ever, is overly confined to intellectual activity. Ethics and politics
are inextricably linked, as Aristotle's writings convey, although Alas-
dair McIntyre stresses that the Greek word used by Aristotle for
politics "covers both what we mean by political and what we mean by
social and does not discriminate between them."' 7 Bioethics in the
context of this Symposium is best understood as a series of actions
with an objective that is ethical and politico-social in nature. Those
attracted to bioethics can view themselves as a group of persons tak-
ing part in such a series of actions over a period of time.
The general objective of bioethics, arising from the special di-
lemmas of human freedom in the late twentieth century, is to guide
the life sciences, including medicine and its institutions, into prac-
tices and actions that respond to and embody some key structural
values and ethical principles of democratic societies-without unjus-
tifiably infringing on the freedom of those engaged in these disci-
plines to seek knowledge and healing within these general limits.'"
This objective of bioethics combines two goals in creative tension:
the goal of ethical guidance and the goal of protection of freedom to
do scientific research and to practice the health sciences (including
medicine) in an optimal cultural climate. This article will show how
academic and scientific freedom has been violated in the United
States in federally-funded fetal, embryo, and fetal tissue research,
Literature, Kennedy Institute of Ethics, Georgetown University, Washington, D.C.
20057. A user can also dial (800)-MED-ETHX. A grant from the National Library of
Medicine of the National Institutes of Health (NIH) supports this collection of docu-
ments. Volume 15 of the Bibliography of Bioethics has 2400 citations listed in over 70
subject areas, and is available from the Center. See 15 BIBLIOGRAPHY OF BIOETHICS
(1989).
15. ENCYCLOPEDIA OF BIOETHICS (W. Reich ed. 1978).
16. Id. at xix.
17. 1 A. MACINTYRE, A SHORT HISTORY OF ETHICS 57 (1966) (emphasis in original).
18. This definition of bioethics combines two factors: action and systematic reflec-
tion on ethical guidance. See R. Fox, supra note 10, at 413-14; T. BEAUCHAMP &J. CHIL-
DRESS, PRINCIPLES OF BIOMEDICAL ETHICS 21 (3d ed. 1989). The emphasis on
"unjustifiable infringement" on freedom of clinicians and scientists reflects a strong
commitment to the academic and scientific freedoms underlying the bioethics move-
ment. When scientific freedom is restricted or infringed, it needs to be done in the
context of a reasoned and systematic argument. See id. at 53. Such reasoned and sys-
tematic argument is conspicuously missing from government actions and statements
that attempt to suppress reproductive biology research in the federal sector.
[VOL. 50:859864
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with great losses of benefits to patients, families, and society. This
situation ought to be of utmost concern to all who espouse the ob-
jective of bioethics.
Since the 1960s, the ethical principle of respect for persons and
their autonomous choices has guided significant changes in research
and practice procedures. As illustrated below in a brief history of
bioethics, respect for and protection of research subjects and pa-
tients was and remains one of the bioethics movement's primary
concerns. The ethical gains of the past must not be lost. However,
the ethical imperatives of the present and future require that the
bioethics movement in the United States balance the principle of
respect for persons with the principle of justice. Unfair access to
adequate health care (and to the benefits of clinical research) for
millions of Americans is arguably our most egregious social prob-
lem.' 9 Our society's tolerance of unequal access to health care and
unequal opportunities to participate in research poses the single
greatest threat to the well-being of the next and future generations
in the United States, especially because of the lack of adequate ac-
cess to preventive prenatal care and genetic services.2 0
In addition to these enormous inequities, the contradictions
posed by the over-restrictiveness and even suppression of clinical
research in reproductive genetics and embryology in the federal sec-
tor manifest an urgent need for national action to address this
bioethical issue. Also, local and regional efforts to develop institu-
tional ethics programs that will serve their communities are
needed.2 ' Major resources of the bioethics movement need to be
committed to these issues in the near future. Ethics committees, the
subject of Wolf's paper, will do their work in a larger cultural cli-
mate in which these issues circulate and demand attention. And, to
19. See Bayer, Callahan, Caplan & Jennings, Toward Justice in Health Care, 78 AM. J.
PUB. HEALTH 583 (1988).
20. See INSTrrUTE OF MEDICINE, PRENATAL CARE-REACHING MOTHERS, REACHING IN-
FANTs (1988).
In 1985, 76.2 percent of all United States infants were born to women who
began prenatal care in the first trimester of pregnancy, 18. 1 percent were born
to women who delayed care until the second trimester, 4.0 percent to women
who obtained care only in the third trimester, and 1.7 percent to mothers who
had no prenatal care at all. When key statistics are analyzed to determine rates
of adequate care rather than trimester of onset, a slightly different picture
emerges. In 1985, only 68.2 percent of all women obtained adequate prenatal
care, 23.9 percent had an intermediate level of care, and 7.9 percent of all preg-
nant women had inadequate care.
Id. at 17.
21. See infra at 875-78 (discussing institutional ethics programs).
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the extent that ethics committees are a consequence of the bioethics
movement, their work will be affected by the objectives of that
movement. The next Part will trace briefly the history of the
bioethics movement with the aid of the works of Fox and others.2
It focuses on the four main stages of the movement, the principal
concern of each, and the institutional changes that endured.
II. FOUR STAGES OF BIOETHICAL CONCERN
A. Research Ethics
The earliest bioethical problem concerned the lack of sound
guidance in research ethics and the need to shape a body of research
ethics to protect human subjects and investigators. This issue sur-
faced after the Nuremberg war crimes trials and crested in the early
to mid-1960s. 2' Henry Beecher was the leader who sounded ethical
alarms and educated other scientists to this concern.24 However, far
too little credit has gone to leaders who initiated policy and social
changes that laid the groundwork for institutional review boards
and research ethics policy in the United States.25
In the late 1950s and early 1960s, there was a vigorous debate
about how best to protect research subjects from researchers' zeal
and how to protect researchers themselves from conflicts of interest
that arose when conducting experiments with their own patients.
Was the best protection in "informed consent" and the consciences
of responsible investigators? Or was it primarily in prior group re-
view of research, supplemented by these other two elements? The
first principle of the Nuremberg Code 2 6 requiring an absolute ap-
22. See generally Callahan & Campbell (eds.), Theology, Religious Traditions, and Bioethics,
HASTINGS CENTER REP.,July-Aug. 1990, special supp., at 1; Fox, supra note 10; Toulmin,
How Medicine Saved the Life of Ethics, 25 PERSP. BIOLOGY & MED. 736 (1982).
23. See, e.g., I. LADIMER & R. NEWMAN, CLINICAL INVESTIGATION IN MEDICINE: LEGAL,
ETHICAL AND MORAL ASPECTS 116-19 (1963); Langer, Human Experimentation: Cancer Stud-
ies at Sloan-Kettering Stir Public Debate on Medical Ethics, 143 SCIENCE 551 (1964).
24. See Beecher, Ethics and Clinical Research, 274 NEW ENG. J. MED. 1354 (1966); see
also Rothman, Ethics and Human Experimentation-Henry Beecher Revisited, 317 N. ENG. J.
MED. 1195 (1987); D. ROTHMAN, STRANGERS AT THE BEDSIDE 70-100 (1991).
25. Two of these persons were James Shannon and Luther Terry, who respectively
held the positions of director of the NIH and Surgeon General in the mid 1960s when
the policy on prior group review was being shaped; cf. Fletcher, The Evolution of the Ethics
of Informed Consent, in RESEARCH ETHICS 222 (K. Berg & K. Tranoy eds. 1983).
26. See M. PAPPWORTH, HUMAN GUINEA PIGS 188 (1967). The "so-called Nuremburg
Code is a judicial summary of the expert testimony presented in the case against the
Nazi doctors accused of war crimes .... The code consists of ten clauses of which the
first is the most important and is developed in the greatest detail .... " The first clause
states that the voluntary consent of the human subject is absolutely essential.
866 [VOL. 50:859
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proach to the research subject's voluntary informed consent was the
focus of much debate suggesting that informed consent was the pri-
mary way to protect subjects. In my view, this emphasis was mis-
taken and overlooked the opportunity in the planning stages of
research to protect subjects and balance the interests of researchers.
A disinterested group of peers, including laypersons, should con-
duct a group review session to scrutinize potential risks to the sub-
jects before the research begins. Only after the research risks and
benefits have been anticipated should attention be given to the ar-
rangements for and content of informed consent. Group review
also should consider when the research should start and how sub-
jects will be recruited and selected.
In 1966, after the occurrence of several disasters caused by the
lack of well-articulated research ethics, 7 a Public Health Service
policy was promulgated to the effect that any grant proposal or con-
tract to involve human subjects in research could be considered only
after a local prior group review had found the proposed project and
its plans for informed consent ethically acceptable.28 Policy makers
finally faced the primary ethical question in research: ought the
project be done at all? The self-interest of researchers must be
checked and balanced by a countervailing interest in the protection
of human subjects. This check and balance system guards against
the researchers' own vulnerability to excessive risk-taking in the
name of science.
In 1974, federal law and regulations made each grantee institu-
tion responsible for ensuring that it had an interdisciplinary institu-
tional review board with at least one member coming from the
public to conduct prior group review. 9 These bodies are publicly
regulated in that the National Institutes of Health (NIH) has author-
27. Id. (documenting experiments made on hospital patients). Patients died as a re-
sult of investigators taking
risks with patients of which those patients . . . [were] not fully aware, or not
aware at all, and to which they would not [have] consent[ed] if they ... [had
been] aware; . . . subject[ing] them to mental and physical distress which . . .
[was] in no way necessitated by, and ha[d] no connection with, the treatment of
the disease from which they ... [were] suffering; and in some cases deliberately
... retard[ing] the recovery from that disease so that investigation of a particu-
lar condition . . [could] be extended.
Id. at 3.
28. See 45 C.F.R. § 46.103 (1990).
29. See Protection of Human Subjects, 45 C.F.R. § 47.107; see aLso SURGEON GENERAL,
U.S. PUB. HEALTH SERVICE, DEP'T OF HEALTH, EDUCATION & WELFARE, PPO No. 129,
INVESTIGATIONS INVOLVING HUMAN SUBJECTS, INCLUDING CLINICAL RESEARCH: REQUIRE-
MENTS FOR REVIEW TO INSURE THE RIGHTS AND WELFARE OF INDIVIDUALS (1966); National
Research Service Award Act of 1974, Pub. L. No. 93-348, § 472, 88 Stat. 342 (1974).
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ity to review the membership and to stop research under certain
conditions."0 Federal regulations prohibit the conduct of research
with human subjects absent institutional review board approval.3 1
Today the institutional review board remains the institutional ex-
pression of the decisions and events of this period and the locus of
accountability for institutional research ethics.
In 1975, federal regulations mandated the creation of an Ethics
Advisory Board (EAB) to advise the Secretary of the Department of
Health and Human Services (HHS) on research proposals that
presented significant ethical issues with long-range consequences,
such as research involving human embryos, fetuses, prisoners, and
children.12 This national group was designed to be a forum for na-
tional debate and advice. An EAB functioned between 1977 and
1979 but was allowed to lapse and has not been rechartered, in vio-
lation of federal law and regulations." The suppression of research
in the federal sector and the collapse of all national forums designed
to discuss bioethical issues ought to be of major concern to local
and regional groups.
B. Education in Ethics and Humanities
The second major bioethical concern was to improve and ex-
pand ethics and humanities education among medical and nursing
students. 4 In the late 1960s and 1970s, many educators started
"humanities programs" in medical and nursing schools. The Soci-
ety of Health and Human Values, founded in 1968, paved the way
for many of these changes. Many ethics programs, especially those
set up in academic medical centers, had their origins in such educa-
tional efforts. Some, like Albert Jonsen, who pioneered the area of
ethics consultation were not physicians, but were educators at the
time they first received requests for consultation.3 5 Virtually all
medical and nursing schools today have some course that focuses on
the study of ethical problems, and many have courses in other as-
pects of the humanities. The institutional expression of this second
30. See 45 C.F.R. §§ 46.112 (1990).
31. See id. § 46.103.
32. See id. § 46.204.
33. See id.
34. See, e.g., Pellegrino, Human Values and the Medical Curriculum-An Educator's Re-
sponse, 209J. A.M.A. 1349 (1969) (one of 20 articles in that issue ofJ. A.M.A. addressing
this movement in the health sciences education community).
35. See Jonsen, Can an Ethicist Be a Consultant?, in FRONTIERS IN MEDICAL ETHICS: AP-
PLICATIONS IN A MEDICAL SETrING 157-71 (V. Abernethy ed. 1980).
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phase of bioethical concern was a change in the curricula and facul-
ties of medical and nursing schools in the United States.
Other key educational institutions were founded in this period,
as well. The founding of the Hastings Center in 1969 and the Ken-
nedy Institute of Ethics in 1971 were further expressions of public
and academic concern for education. These institutions played a
prominent role in the dissemination of research, discussion, and
literature about ethical issues in medicine and other life sciences.
Without them, the growing literature and dialogue about bioethical
concerns could not have been possible. The Park Ridge Center, a
third major institutional force, has emerged in the 1980s, and gives
expression to broad religious themes in the ethical analysis of
health, health care, and research. Today, there are more than a
hundred bioethics organizations of various types in the United
States and Canada. 6
C. Ethical Concerns in Patient Care and Access to Health Care
The third stage of bioethical concern focuses on ethical
problems in patient care and inequities in the delivery of health care
in the United States. In the last decade, the dominant ethical issue
in patient care in hospitals and long-term care facilities was that of
foregoing life-sustaining technologies. Possibly beginning with the
Karen Ann Quinlan case, but prefaced by issues of patient selection
for dialysis and transplants, concern about ethical issues in the care
of terminally ill or incapacitated patients has dominated patient care
ethics.3 7 At the same time, a contradictory problem loomed large-
outside the institutions' doors, the greatest ethical issue was access
to basic health care.
During this period, the hospital ethics committee was born. 8
36. See KENNEDY INSTITUTE OF ETHICS, INTERNATIONAL DIRECTORY OF BIOETHICS OR-
GANIZATIONS (1989).
37. PRESIDENT'S COMMISSION FOR THE STUDY OF ETHICAL PROBLEMS IN MEDICINE AND
BIOMEDICAL AND BEHAVORIAL RESEARCH, DECIDING TO FOREGO LIFE-SUSTAINING TREAT-
MENT (1983) [hereinafter PRESIDENT'S COMMISSION, DECIDING TO FOREGO LIFE-SUS-
TAINING TREATMENT].
38. The first reference to the need for such committees was in a law review article by
a Texas pediatrician. See Teel, The Physician's Dilemma: A Doctor's View: What the Law
Should Be, 27 BAYLOR L. REV. 7 (1975). See also B. HOSFORD, MAKING YOUR MEDICAL
DECISIONS: YOUR RIGHTS AND HARSH DECISIONS TODAY 126 (1982) ("[W]hen Karen
Ann Quinlan was moved to Morris View Nursing Home, administrators there set up an
ethics committee with the membership that Dr. Teel had recommended."). The confu-
sion between what the New Jersey justices wanted from the committee (that is, to settle
the issue on Ms. Quinlan's prognosis), and the self-understanding of the committee as a
source of advice to physicians and patients, is also a matter of record. See id. at 127.
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The Massachusetts General Hospital was one of the first to report
that an optimum care committee3 9 assisted with controversial deci-
sions in its intensive care units. This committee and others like it
that serve hospital staff and patients were the forerunners of the
hospital ethics committee, an institutional expression now well-de-
scribed in the literature.4 ° The President's Commission for the
Study of Ethical Problems in Medicine and Biomedical and Behav-
ioral Research found that institutional ethics committees promoted
good decisionmaking practices in hospitals. 4'
Although most ethics committees have arisen from within insti-
tutions themselves, there are two important exceptions. In the early
1980s, the HHS attempted to make rules requiring "infant care re-
view committees" to provide advice on selective non-treatment
choices for handicapped newborns.42 This attempt eventually was
overturned in American Academy of Pediatrics v. Heckler.43 Today,
Maryland is the only state to require such bodies. Since 1985, state
law has required all hospitals to have a patient care "advisory com-
mittee."'4 4 Diane Hoffmann's evaluation 45 of these committees in
Maryland, the District of Columbia, and Virginia found: (1) a very
low utilization rate;46 (2) infrequent use by patients and families; 47
(3) a lack of awareness of the existence of the committees by health
care professionals;4" and (4) few hospitals in the District of Colum-
bia or Virginia with formal means of notifying patients and families
39. See Optimum Care for Hopelessly Ill Patients: A Report of the Clinical Care Committee of the
Massachusetts General Hospital, 295 NEW ENG. J. MED. 362 (1976).
40. See, e.g., R. CRAIG, C. MIDDLETON, L. O'CONNELL, ETHICS COMMITrEES, A PRACTI-
CAL APPROACH (1986); INSTITUTIONAL ETHICS COMMITTEES AND HEALTH CARE DECISION-
MAKING (R. Cranford & A. Doudera eds. 1984); B. HOSFORD, BIOETHICS COMMITTEES:
THE HEALTH CARE PROVIDER'S GUIDE (1986).
41. PRESIDENT'S COMMISSION, DECIDING TO FOREGO LIFE-SUSTAINING TREATMENT,
supra note 37, at 162-63.
42. See 45 C.F.R. 1340 (1990); Murray, The Final, Anticlimactic Rule on Baby Doe, HAS-
TINGS CENTER REP., June 1985, at 5.
43. 561 F. Supp. 395, 399-400 (1983) (striking down as arbitrary and capricious a
regulation concerning life-sustaining medical treatment to be used to preserve lives of
severely mentally or physically defective newborns, where agency apparently had failed
to consider the disruptive nature or propriety of its action).
44. MD. HEALTH-GEN. CODE ANN. § 19-371 (1990 & Supp. 1990).
45. Hoffmann, Does Legislating Hospital Ethics Committees Make a Difference?: A
Study of Hospital Ethics Committees in Maryland, the District of Columbia, and Virginia
(1991) (to be published in a forthcoming issue of Law, Medicine & Health Care) (unpub-
lished manuscript on file at the Maryland Law Review).
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of the committees' services." 9 Maryland's hospitals perform better
in notifying patients and families, as reported by eighty-eight per-
cent of this state's hospitals.5 ° State laws soon may require such
groups in all health care facilities.
Senators Danforth and Moynihan introduced a bill known as
the Patient Self-Determination Act of 1989, s' which, after amend-
ment and passage,52 required each health care facility receiving
Medicare and Medicaid funds to implement an educational program
designed to assist all patients over eighteen years old in understand-
ing and considering the need for advanced directives for care at the
end of life and for durable powers of attorney for health care deci-
sions. 53 A component of the bill that would have mandated the cre-
ation of hospital ethics committeesM was deleted in conference
because of two countervailing forces: first, the threat that the
Health Care Financing Administration would gain the power to reg-
ulate the committees if the law had passed in that form and second,
because of concern among smaller hospitals about the costs of an
ethics program.55 Memories of the excesses and ideological
problems associated with federal involvement with infant care re-
view committees in "Baby Doe" cases were sufficient to compel the
removal of this aspect of the bill, despite arguments that excesses in
regulation could be confronted by court action as was done in the
"Baby Doe" era. 56
Inadequate and unfairly restricted access to basic health care is
another dominant ethical concern in the United States today. More
Americans are affected adversely by this social problem than by any
other.57 A grassroots bioethics movement has developed in re-
sponse to this tragic problem. Local and regional groups have or-
49. Id.
50. Id.
51. See S. 1766, 101st Cong., 1st Sess. (1989).
52. The bill was finally passed as part of the Omnibus Budget Reconciliation Act of
1990, Pub. L. No. 101-508, § 4206, 104 Stat. 1388 (1990).
53. Id. § 4206(a)(1), 104 Stat. at 1388.
54. See S. 1766, 101st Cong., 1st Sess. §§ 3(a)(3), 4(b)(3) (1989).
55. This information came from a personal communication I had with Gaelynn
DeMartino, a representative of the American Hospital Association, Washington, D.C.
(Feb. 22, 1991). See also Hoffman, Regulating Ethics Committees in Health Care Institutions-Is
It Time?, 50 MD. L. REV. 746, 753 n.46 and accompanying text (1991) (providing an
account of the legislative process).
56. See Capron, The Patient Self-Determination Act: Not Now, HASTINGS CENTER REP.,
Sept.-Oct. 1990, at 36; Fletcher, The Patient Self-Determination Act: Yes, HASTINGS CENTER
REP., Sept.-Oct. 1990, at 34; see also supra note 43 and accompanying text.
57. See 1 PRESIDENT'S COMMISSION FOR THE STUDY OF ETHICAL PROBLEMS IN
MEDICINE AND BIOMEDICAL AND BEHAVIORAL RESEARCH, SECURING ACCESS TO HEALTH
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ganized "town meetings" and other fora to make the populace and
legislatures aware of the inequities in access to health care. Oregon
Health Decisions is the prototype of this kind of movement, which
finds expression in many states today.5"
D. The 1990s: The Next Stage of Bioethical Concern
In the 1990s the bioethics movement needs to: (1) place access
to adequate health care and preventive strategies in health care as
the highest priorities in local, regional, and national activities; (2)
strengthen local institutional ethics programs in health care institu-
tions that also serve their communities; (3) restore freedom of scien-
tific inquiry and federal support for research activities involving the
human fetus, embryo, and fetal tissue transplants; and (4) restore
one or more fora for debate and dialogue about bioethical issues at
the national level. The final Part of the Article discusses each item
of this proposed agenda.
III. A BIOETHICs AGENDA FOR THE 1990S
A. Universal Access to Health Care with Preventive Strategies
The highest priorities on the bioethics agenda for the 1990s are
reforms to ensure fairer access to health care and to implement pre-
ventive strategies. It is unfair to restrict access to health care to
those able to pay for it when an individual's economic opportunity
itself depends in great measure on his or her health and educational
status. Other nations with universal health care provide free serv-
ices to Americans who become ill in their midst. Since these nations
(e.g., Germany, France, United Kingdom, Scandanavian nations, Ja-
pan, etc.) do not spend nearly as much on health care as the United
States, it is only logical to raise the question as to why we cannot do
the same for aliens and strangers who become ill in the United
States.
The adequacy of health care in a developed nation ought to be
evaluated in terms of the following criteria: (1) fairness of access to
adequate health care, measured by the opportunity to be seen by,
consult with, and be treated by qualified physicians and other li-
CARE: A REPORT ON THE ETHICAL IMPLICATIONS OF DIFFERENCES IN THE AvAILBILITY OF
HEAL.TH SERVICES 49-113 (1983) [hereinafter SECURING ACCESS TO HEALTH CARE].
58. Jennings, A Grassroots Movement in Bioethics: Community Health Decisions, HASTINGS
CENTER REP., June-July 1988, special supp., at 1-16 (stating that the Oregon Health De-
cisions program organizes participatory fora at the grassroots level throughout the state,
thus bridging the gap between health care providers and consumer groups, and between
experts and "ordinary" citizens).
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censed health care professionals concerning duly diagnosed health
needs; (2) fairness in distributing among all sectors of society the
economic burdens of health care, research, and education of health
care professionals; (3) scaled preventive strategies to ameliorate the
causes of disorders and conditions that carry the greatest mortality
and morbidity for human beings; and (4) well-tested approaches to
prenatal care and genetic services for those who need them most.5 9
These basic concerns and the growing health needs of the
American people gradually can empower leaders in government, in-
dustry, and labor in the United States to shape and effect a universal
approach to health care and preventive strategies-and not just a
reimbursement plan. In any reformed system we must assume that
in addition to other preventive strategies, adequate prenatal care
and genetic services (for example, screening, counseling, prenatal
diagnosis, and treatment for genetic diseases) will be included in a
basic "floor of services" that will be available to all pregnant women
and to all individuals and families at higher genetic risk, affected by
a genetic disorder, or carrying genes that make them more suscepti-
ble to harm from common disorders or hazards in the workplace.
This concern for access to health care and prevention is both
ethical and political in nature; it is based upon claims of justice as
fairness and predictions that continued refusal to address the moral
and economic crises in health care will lead to a variety of harms and
avoidable disasters. Even barring other major social or biological
calamities, unless present trends change, the contradictions and
costs that exist in the present arrangements will become too bur-
densome to persist into the twenty-first century.
The moral case for a universal health plan grounded in justice
as fairness has been argued in a broad body of literature and com-
mentary."° This literature describes health care institutions as
driven to use technology largely to postpone death, rather than mo-
tivated to prevent or ameliorate the major causes of harm to human
health. Of special political note, this literature describes vast waste
and administrative burdens in health care, as well as harsh inequities
59. These four criteria stem from reflections on the literature cited infra note 60 and
supra note 57.
60. See D. CALLAHAN, SETTING LIMITS: MEDICAL GOALS IN AN AGING SOCIETY (1987)
[hereinafter SETTING LIMITS]; D. CALLAHAN, WHAT KIND OF LIFE? THE LIMITS OF MEDI-
CAL PROGRESS (1990); N. DANIELS, JUST HEALTH CARE (1985); C. DOUGHERTY, AMERICAN
HEALTH CARE: REALITIES, RIGHTS, AND REFORMS (1988); 1 SECURING ACCESS TO HEALTH
CARE, supra note 57, at 11-46; Outka, SocialJustice and Equal Access to Health Care, 2J. REL.
ETHICS 11 (1974); Wikler, Philosophical Perspectives on Access to Health Care: An Introduction,
in 2 SECURING ACCESS TO HEALTH CARE, supra note 57, at 107, 129-42.
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that reflect economic, racial, and educational differences. 6 The
moral case for judgment and reform is clear. The burden to rebut
the compelling arguments in favor of these changes rests on those
who oppose a national health plan.
Beyond the fairness issues, the success of human gene mapping
and the growing scope of testing for genetic diseases will also ease
the way for development of a more universal plan. The health care
plan of the future will probably see an equal emphasis on personal
responsibility for health and a recognition of the role that genetics
plays in disease. In the future, more Americans will see that they are
not to blame for cancer, diabetes, heart disease, or other common
disorders. Genetics is a great equalizer in the realm of disease.
Eventually, most people will understand that they suffer from dis-
eases as a result of some genetic predisposition. At that time, insur-
ers will be forced by a more enlightened nation not to exploit
persons at higher risk with the highest premiums. We will need a
sufficient pool of social insurance to share and bear these risks and
burdens.62
An important caveat to this argument is that progress toward a
national health plan may take many years, and controversies will
arise about the inclusion of genetic services in the plan because of
their present association with abortion. For example, health plan-
ners in the Bush Administration envision only a modicum of genetic
services in the national health plan in the year 2000, such as screen-
ing maternal and newborn serum for alpha-fetoprotein. The plan-
ning documents are devoid of any references to genetic screening of
carriers, prenatal diagnosis, abortion, or genetic therapy. 63 Ameri-
cans can learn much about the role of genetic services by studying
the total health care systems of other nations. 64
61. See, e.g., C. DOUGHERTY, supra note 60, at 7, 15, 142, 178, 209 n.30 (discussing
burdens due to racially based unequal access, health care costs and administrative
waste); D. CALLAHAN, SETrING LIMITs, supra note 60, at 115-17, 119-23 (discussing finan-
cial pressure on the government due to indiscriminate spending on health care and gen-
eral administrative burdens).
62. See Fletcher & Wertz, Ethics, Law, and Medical Genetics: After the Human Genone Is
Mapped, 39 EMORY L.J. 747, 756-58 (1990).
63. Public Health Service, Bureau of Maternal and Child Health, Promot-
ing/Preventing Disease: Year 2000. Objectives for the Nation (1990) (draft memoran-
dium). Today, the United States is the only developed nation whose elected leaders,
because of moral opposition to abortion, plan to reduce genetic services. Americans will
eventually decide-in their own enlightened self-interest-to chart the course of the na-
tion's health in more moderate ways, inclusive of genetic services and other forms of
health care grounded in preventive medicine and public health.
64. See generally D. WERTZ & J. FLETCHER, ETHICS AND HUMAN GENETICS: A CROSS-
CULTURAL PERSPECTIVE (1989).
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B. Strengthening Local Institutional Ethics Programs
A second objective of the bioethics movement in the next dec-
ade is to organize outreach and training resources to provide health
care institutions with an opportunity to start or strengthen their own
institutional ethics programs that also serve the local communities.
For this task to be accomplished, older bioethics centers-especially
those in clinical settings-will need to prioritize service and out-
reach efforts alongside their traditional activities of research, teach-
ing, and policy analysis.
A programmatic approach, with strong institutional and com-
munity support, will check and balance the self-protective character
of some ethics committees that Wolf describes. The word "pro-
gram" implies a planned approach that an institution's leaders place
in a "must do" category, rather than an ad hoc "nice to do" cate-
gory. The strength of the combined elements in a program will un-
dergird and broaden the effectiveness of the ethics committee. Too
many hospital ethics committees fail or flounder for lack of institu-
tional support and recognition, as well as underuse of their central
functions.6 5 Too many ethics consultants in health care operate in
the absence of identifiable programs or structures of accountability.
By making ethics programs a priority, those necessary elements can
be knit together for a systematic approach in hospitals and commu-
nities to service, education, and research on ethical problems in
clinical care. The time has come for ethics programs to be part of
the culture of health care and to gain enough independence and
community support to be viewed as credible institutions. 'In the
1990s, ethics programs must become accepted actors in the health
care arena and the communities they serve, just as prior group re-
view is part of the culture of research and researchers.
A full institutional ethics program has five necessary elements:
(1) a duly appointed and constituted interdisciplinary ethics com-
mittee with community members; (2) a clinical ethics and health care
law education program for professional staff and community mem-
bers; (3) ethics consultation on request; (4) at least two resource
persons within the institution with advanced education in clinical
ethics and health care law; and (5) resources to evaluate the four
elements of the program and to conduct research on the dynamics
and causes of ethical problems that arise in the clinical and commu-
nity settings.
65. See supra notes 46-49 and accompanying text.
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1. Institutional Ethics Committees.-Some of the causes contribut-
ing to the need for institutional ethics committees are:
(1) new choices about the uses and applications of powerful
medical technologies,
(2) ethical pluralism,
(3) the value of patient self-determination,
(4) the value of sharing decisionmaking with family,
(5) court and national commission recommendations,
(6) the perceived threat of medical malpractice suits, and
(7) media attention given to ethical issues in public life.
The ideal composition and activities of ethics committees has
been well described elsewhere.66 The ethics committee has four
major functions: (1) to provide a forum to which any member of the
institution or community can bring an ethical issue related to patient
care; (2) to sponsor or provide education for the staff and commu-
nity on ethical issues and related health care law or policy; (3) to
sponsor or provide ethics consultation upon request; and (4) to as-
sist in the development of policies and guidelines on issues with eth-
ical content.
In addition, the ethics committee also ought to oversee the
other four elements of the ethics program discussed in the following
sections. The ethics committee in a health care setting should be
defined and constituted as an official committee of the institution
(with all of the protections afforded hospital committees by state
law), responsible to the governing body of the institution, and con-
nected by function to the medical or clinical staff of the institution.
Placing ethics committees under the control of the medical or
clinical staff rather than making them directly accountable to the
governing body would stifle their independence in many settings
and would erode stronger community support and credibility.
Community support for the institutional ethics committee can be
garnered in a number of ways, for example by holding town meet-
ings, inviting community members to observe committee meetings,
asking community leaders for ideas, inviting community members to
take part in the committee's educational programs, and using the
ethics consultation process when appropriate.
66. See supra note 40; see also Kanoti & Vinicky, The Role and Structure of Hospital Ethics
Committees, in HEALTH CARE ETmICS: A GUIDE FOR DECISION MAKERS 293 (G. Anderson &
V. Glesnes-Anderson eds. 1987). For the best practical guide to ethics committees'
work, see J. Ross, C. BAYLEY, V. MICHEL & D. PUGH, HANDBOOK FOR HOSPITAL ETHICS
COMMITrEES (1986).
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2. Education in Clinical Ethics and Health Care Law.-The ethics
committee must sponsor and provide the second element of the
program: education in the form of an on-going course or annual
series of programs in clinical ethics and health care law for profes-
sional staff and, if possible, for the community as well. The goal of
this aspect of education is to expose the staff and the community to
the most common ethical problems. Staff education is vital because
physicians, nurses, and other clinicians are the people best able to
identify and resolve ethical problems that arise daily in clinical care.
These same professionals must learn to identify legal issues in their
medical cases, become less afraid of legal threats, and know when to
seek legal advice. Ideally, the educational program or course will
become so well regarded and evaluated that eventually it will be-
come part of the orientation and continuing education process for
health care professionals associated with the institution.
One approach to teaching clinical ethics and health care law to
health care professionals suggests holding training sessions and
small group meetings to discuss issues such as:
(1) communication to promote informed consent and shared
decisionmaking, and how to address major breakdowns in
communication,
(2) truth-telling and disclosure dilemmas,
(3) privacy and confidentiality,
(4) determining patient capacity,
(5) informed consent to treatment,
(6) refusal of treatment,
(7) foregoing life-sustaining treatment,
(8) terminal illness,
(9) reproductive health care choices,
(10) access to health care,
(11) controlling the costs of health care, and
(12) allocation of health care resources. 67
The list includes "major breakdowns in communication" as an
ethical rather than an "emotional" problem. The rationale for this
characterization is that good communication between health care
professionals and their patients is necessary to informed and shared
decisionmaking. When communication breaks down, shared deci-
sionmaking is impossible. When poor communication threatens the
67. See INTRODUCTION TO CLINICAL ETHICS AND HEALTH CARE LAW (I. Fletcher & M.
White eds. 1991) [published by Ibis Publishing Co., copy available c/o In-Print, 7 El-
liewood Ave., Charlottesville, VA 22903].
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integrity of the physician-patient relationship, the threshold of an
ethical problem has been reached.
Practical education in the above areas, based on cases that clini-
cians can identify as paradigms, help to equip them for the everyday
tasks of working through ethical problems and familiarize them with
the relevant legal issues that arise within such cases. If staff mem-
bers are prepared for everyday problems, they will be more likely to
recognize situations in which they should request ethics
consultations.
3. Ethics Consultation: Definition and Need.-Possibly a major
reason why ethics committees have received unfavorable evaluations
by clinicians and others results from the built-in inadequacies of
whole committees as primary providers of ethics consultation.68
The function of consultation on a request to assist with ethical
problems that arise in the care of particular patients must be differ-
entiated from the function of the ethics committee as a forum where
anyone can bring an ethical issue for discussion. Consultation can
be provided in a number of ways: (1) the whole committee can act
as a consultant, under the leadership of the chairperson, who is the
contact person for consults; (2) a sub-group of the committee can
provide consultation under the leadership of the chairperson or a
designated leader, using the whole committee as a second-tier when
needed; (3) the ethics committee can delegate consultation respon-
sibilities to an ethics consultation service (whose members may dif-
fer from or include some of the committee members) that acts on
behalf of the committee, reports to it, and evaluates when a second-
tier consultation by the entire ethics committee is necessary; or (4)
ethics consultation can be delegated to one or more individuals.
The fourth option may be a good choice for small institutions, but
should not be used without committee oversight of the consultants'
activities.
Differentiation between the consultation function and the com-
mittee function is important. The ethical problems that arise in
patient care may involve very personal and private material.6" Often
the parties already are angry with one another and have exchanged
threats of various types, including threats to sue. The prospect of
68. See, e.g., Lo, Behind Closed Doors: Promises and Pitfalls of Ethics Committees, 317 NEW
ENG. J. MED. 46 (1987); Siegler, The Progression of Medicine: From Physician Paternalism to
Patient Autonomy to Bureaucratic Parsimony, 145 ARCH. INT. MED. 713 (1985); Moreno, Ethics
By Committee: The Moral Authority of Consensus, 13 J. MED. & PHIL. 411 (1988).
69. See C. CULVER, ETHICS AT THE BEDSIDE (1990).
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entering a conference room and sharing these private disputes with
a large number of strangers raises anxieties and creates a "tribunal-
istic" flavor. Also, many physicians may prefer not to bring this dis-
pute into a committee setting initially, but would be open to
consultation in the traditional sense. Such consultation must be
personal, timely, and must take place in or near the patient's room
in the hospital or nursing home.
Ethics consultation involves the provision of specialized help on
request, to identify, analyze, and resolve ethical problems that arise
in clinical care. 70 There are numerous compelling needs for ethics
consultation. The major need for such assistance arises when good
faith attempts to resolve ethical problems fail and parties are in-
volved in a dispute that materially affects the continuity of care of
the patient or concerns a problem of conscience for one or more of
the health care team. Ethics consultation also is needed to resolve
the very complex cases that occur rather frequently in health care
situations today. Consultation helps to keep health care providers'
fears of liability from interfering with good medical practice and to
reduce the number of "unnecessary" malpractice suits-suits that
arise because ethical problems left unresolved at the bedside smol-
der and then flame into disputes. Ethics consultation-informed by
health care law---often can clarify misunderstandings of law, reduce
legal threats, and resolve the problems in the case on ethical
grounds. Figures from the Bureau of Insurance in Virginia on the
incidence of settlement of medical malpractice suits show that in
sixty-one to seventy-two percent of the cases settled between 1985
and 1987, no money was awarded to the plaintiffs.7 ' Whether many
of these cases involved resolvable ethical disputes remains unknown
pending further study, but such a hypothesis must be advanced.
Moreover, prevention of unnecessary malpractice suits through the
use of ethics consultation services would lower the costs of health
care and reduce a trend toward "defensive medicine."
70. Ajoint planning session of board members of the Society for Bioethics Consulta-
tion (SBC) and invited guests agreed on this definition in May 1988, prior to the Second
National Conference on Ethics Consultation in Health Care. The Society is a nonprofit,
national organization that exists to encourage ethics consultation in health care and the
continuing education of those who provide it. Membership is open to interested per-
sons by writing to: Laurence O'Connell, Ph.D., President, SBC, c/o Park Ridge Center,
676 St. Clair, Suite 450, Chicago, IL 60611. For papers from the first National Confer-
ence on Ethics Consultation in Health Care, see J. FLETCHER, N. QUIST & A. JONSEN,
ETHICS CONSULTATION IN HEALTH CARE (1989).
71. STATE CORPORATION COMMISSION, REPORT TO THE GOVERNOR AND THE GENERAL
ASSEMBLY OF VIRGINIA ON ALTERNATIVE PREMIUM DISTRIBUTION METHODS FOR MEDICAL
MALPRACTICE INSURANCE, H. DOC. No. 33 12 (1989).
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In addition to its usual functions as a forum for discussion of
ethical issues, policy development, and health education, the ethics
committee should provide or oversee ethics consultation on re-
quest. The ethics committee must also study how best to provide
ethics consultation in the institution.
Whichever methodology is used, the primary responsibility for
ethics consultation should reside in the ethics committee, which
should be accountable for the quality of the consultations it con-
ducts or authorizes. The committee must oversee the activities of
the consultants to prevent the potential harms that can arise from
the following situations: Unchecked ethical bias of one or more
consultants; role confusion that results in ethics consultants issuing
medical orders or giving legal advice; consultants operating in a
loose, undefined manner without clear guidelines for proper consul-
tation procedure; or ethics consultants becoming involved in cases
without the knowledge of the attending physician or the patient.
Each institution must promulgate a policy statement to define
the goals, functions, and responsibilities of its institutional ethics
committee. The existence of a policy on ethics consultation reas-
sures consultants that they have institutional support. The policy
also will help to protect them and others involved in the case from
ethical or legal challenges made during or after the consultation.
An institutional policy statement on ethics consultation should
have seven features:
(1) a philosophy locating responsibility for ethical decision-
making with clinicians and patients,
(2) a statement of encouragement to clinical staff to request
consultation under certain conditions,
(3) assurances that anyone who requests a consultation will be
protected from intimidation,
(4) an ethically and legally sound approach to receiving re-
quests for consultation,
(5) a protocol for ethics consultation,
(6) a statement that ethics consultation will be provided free of
charge, and
(7) an accountability structure for ethics consultation.7 2
The institution must rely on educated clinicians to respond to
ethical problems and encourage them to request ethics consultation,
72. See generally J. FLETCHER, N. QUIST & A. JONSEN, supra note 70; see also e.g., infra,
Appendix A (policy statement adopted at the University of Virginia Health Sciences
Center).
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especially in three situations: when their best efforts to resolve an
ethical problem are unsuccessful and the problem is provoking a
dispute in which they are involved; when a patient has no guardian,
family member, or appropriate surrogate decisionmaker; and when
a very complex case with ethical problems arises.
The policy of no billing for ethics consultations is based on the
principle that it is the hospital's obligation to make ethics consulta-
tion services available to patients, much as religious and social work
organizations provide professional services without direct charge.
The decision not to charge for consultation services is also appro-
priate because some ethical problems are systemic and are not
caused by the individual patient.7" However, although patients
should not be charged separate fees for ethics consultations, their
hospital bills will reflect the costs of the salaries and facilities needed
to support these services.
4. Resource Persons in Clinical Ethics.-As the institutional ethics
program is strengthened, it will require continued nurturing. Each
institution will need resource persons to support and implement the
elements in the program, in addition to a strong ethics committee
chairperson who is able to relate as a peer both to clinical staff and
administrators. An institutional ethics program requires at least two
resource persons, in addition to an effective chairperson, to fulfill
these roles. Ideally, one resource person should be a physician and
the other should be another health care or health-related profes-
sional, such as a nurse, administrator, chaplain, or social worker.
The more solid their community connections, the stronger will be
their abilities to strengthen those aspects of the program that in-
volve community members. The institution must recognize and fi-
nance the time that the resource persons and chairpersons spend in
performing their functions.
These resource persons should be trained at existing clinically-
73. One such common systemic ethical problem often arises in cases involving con-
flict about foregoing life sustaining treatment. It is the policy in most hospitals that
unless there is a written order to the contrary, a patient will be resuscitated, and medical
personnel are trained to act immediately to resuscitate. This institutional position created
ethical problems for many patients who had not prescribed specific instructions in ad-
vance, but who, had they been able to speak, would have refused to be resuscitated.
Another common systemic problem involves the obligation of confidentiality, described
in most medical codes of ethics and believed by most patients, which frequently is
breached during routine medical care in modem hospitals-perhaps more than 100 per-
sons see the patient's chart and know intimate details about the patient's life. See Sie-
gler, Confidentiality in Medicine-A Decrepit Concept, 307 NEW ENG. J. MED. 1518 (1982).
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based bioethics centers. The training should enable local resource
persons to:
(1) assist the members of the ethics committees to educate
themselves concerning relevant issues,
(2) teach in the clinical ethics education program,
(3) keep up with ethics and health care law, and literature,
(4) speak in the hospital and community on request, and
(5) serve as ethics consultants or as resources to those who are
consultants.
This training program can be one element in an outreach pro-
gram for health care institutions whose leadership desires to
strengthen or start an ethics program.1
4
5. Evaluation and Research.-The fifth feature of an ethics pro-
gram is the capacity to evaluate the efficacy of the four aspects of the
ethics program, specifically the strengths and weaknesses of case
consultation and of the clinical ethics education program. Ethics
programs also can sponsor research on the causes and dynamics of
the most frequent ethical problems that arise in health care
institutions.
C. Remedies for Suppression of Research in Reproductive Biology
in the Federal Sector
The bioethics movement needs to turn attention and resources
to the fact that in the federal sector, basic and clinical research in
reproductive biology is suppressed unjustifiably. Scientific freedom,
one of the central tenets of the bioethics movement, is being vio-
lated in this area of science. Ironically, a bioethics movement that
began by helping to restrict research needs today to help to free a
crucial area of science from unreasonable bans, moratoria, and lack
of support. Also, since Rust v. Sullivan,75 control and suppression of
physician communication about abortion services with patients
served in federally-funded family planning clinics has been added to
suppression of scientific activities with the fetus or embryo. The
growing incidence of violations of scientific freedom, free speech,
and professional responsibility ought to be of paramount concern.
This issue cuts across research, patient care, and community
74. The statewide outreach program of the Center for Biomedical Ethics at the Uni-
versity of Virginia is entitled "Developing Hospital Ethics Programs." In the next year,
DHEP will complete a two-year project to assist 20 community and private hospitals in
Virginia to start or strengthen institutional ethics programs. See infra Appendix B.
75. 111 S. Ct. 1759 (1991).
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medicine. These actions fundamentally violate a key element in the
objective of the bioethics movement.
How did this situation develop? A process of restricting investi-
gative research concerning the fetus and human embryo that was
developed in the 1970s has gradually become a defacto policy of sup-
pression. 76 In the 1970s two Congressionally appointed groups
made recommendations that cautiously encouraged and also sharply
restricted fetal and pre-embryo research." The recommendations
for fetal research of the National Commission for the Protection of
Human Subjects of Biomedical and Behavorial Research were
adopted as federal regulations in 1975.78 One of the key recom-
mendations was the formation of an Ethics Advisory Board (EAB) to
advise the Secretary of Health and Human Services on ethical
problems in research, including fetal and embryo research. 79 In ef-
fect, almost no fetal research and no embryo research at all could be
done without EAB approval and advice to the Secretary. The mod-
est encouragement of these regulations for limited investigational
fetal research was then undone by bureaucratic fiats and actions of
Congress in the 1980s that remain unchanged. 80 One major bu-
reaucratic fiat has been the disbanding and refusal to recharter an
EAB, after a brief existence between 1977 and 1979. Another fiat
has been the refusal of any HHS Secretary to approve the EAB's
recommendations to Secretary Califano in 1979 to permit federal
funding to study in vitro fertilization and untransferred pre-em-
bryos.8 1 As a consequence, American research in reproductive biol-
ogy and allied scientific fields has lost significant ground.
76. See J. Fletcher, Restriction and Suppression of Fetal and Pre-Embryo Research
1974-1990, University of Iowa, Conference on the Beginning of Human Life (Nov. 4-7,
1990) (copy on file with Maryland Law Review).
77. These two national groups and their reports are THE NATIONAL COMM'N FOR THE
PROTECTION OF HUMAN SUBJECTS OF BIOMEDICAL AND BEHAVORIAL RESEARCH, U.S. DEP'T
OF HEALTH, EDUCATION & WELFARE, PUB. No. 76-127, REPORT AND RECOMMENDATIONS:
RESEARCH ON THE FETUS 61-68 (1975), and the ETHICS ADVISORY BOARD, REPORT AND
CONCLUSIONS: HEW SUPPORT OF RESEARCH INVOLVING HUMAN In Vitro Fertilization and
Embryo Transfer (May 4, 1979).
78. See 45 C.F.R. §§ 46.201-.21 1 (1990).
79. See THE NATIONAL COMM'N FOR THE PROTECTION OF HUMAN SUBJECTS OF BI-
OMEDICAL & BEHAVIORAL RESEARCH, U.S. DEP'T OF HEALTH, EDUCATION & WELFARE, PUB.
No. (05)76-127, REPORT AND RECOMMENDATIONS: RESEARCH ON THE FETUS 70 (1975).
80. For a good history, see ASSOCIATION OF AMERICAN MEDICAL COLLEGES, FETAL
RESEARCH AND FETAL TISSUE RESEARCH (1988). For congressional action, see Health
Research Extension Act of 1985, Pub. L. No. 99-158, § 498, 99 Stat. 820, 877 (1985)
(restricting fetal research).
81. ETHICS ADVISORY BD., U.S. DEP'T OF HEALTH, EDUCATION & WELFARE, REPORT
AND CONCLUSIONS: HEW SUPPORT OF RESEARCH INVOLVING HUMAN In Vitro Fertilization
and Embryo Transfer 100-14 (1979); see also 44 Fed. Reg. 35 (1979).
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Webster's defines suppression as: "la: to put down or out of
existence by or as by authority, force or pressure; b: to force into
impotence or obscurity."82 Both definitions apply to fetal research
in the federal sector today. Only a small amount of federally funded
investigational fetal research has occurred since it was permitted
and restricted by federal guidelines."3 A review of extramural
grants by the National Institutes of Child Health and Human Devel-
opment for projects on high risk pregnancy and fetal pathophysi-
ology for 1983-84 showed that of 183 projects, no more than three
involved instances of human fetal research that even approached the
threshold of minimal risk.84 In this period investigators developed
the chorionic villus sampling approach to prenatal diagnosis using
new methods from molecular biology for direct diagnosis of fetal
DNA.8 5 However, institutional funds and patient fees supported
this research. Also at this time some positive results were attained
in fetal therapy.8 6 However, with the exception of one experiment
in one case of fetal therapy 7 the federal role in research on fetal
therapy was minimal and advisory only.
Three types of reforms are needed in the area of federal fetal
regulations. One is to create a specific framework for the definition
of "minimal risk," the threshold at which investigational fetal re-
search is permitted. 8 The second is to allow greater than minimal
research risks in the first trimester of pregnancy, a level now permit-
ted in research with living children.8 9 A third is the lack of a stan-
dard to permit approval, after national review, for selective
exposure of fetuses to be aborted to higher research risks before
exposing fetuses intended for delivery to such risks.
82. WEBSTER'S THIRD NEW INTERNATIONAL DICTIONARY 2298 (3d ed. 1981).
83. See 45 C.F.R. §§ 46.201-.210 (1990).
84. Fletcher & Schulman, Fetal Research: The State of the Art, The State of the Question,
HASTINGS CENTER REP., Apr. 1985, at 6, 8.
85. See D. WEATHERALL, THE NEW GENETICS AND CLINICAL PRACTICE 114-19 (1985).
86. See Fetal Therapy, 29 CLIN. OBSTET. & GYNEC. 481-614 (1986).
87. Evans, Chrousos, Mann, Larsen, Green, McCluskey, Loriaux, Fletcher, Koons,
Overpeck & Schulman, Pharmacologic Suppression of the Fetal Adrenal Gland In Utero: At-
tempted Prevention of Abnormal External Genital Masculinization in Suspected Congenital Adrenal
Hyperplasia 253 J. A.M.A. 1015-20 (1985).
88. See 45 C.F.R. § 46.102(g) (1990) ("minimal risk" means that the risks of harm
anticipated in the proposed research are not greater, considering probability and magni-
tude, than those ordinarily encountered in daily life or during the performance of rou-
tine physical or psychological examinations or tests).
89. See id. § 46.405 (HHS will conduct or fund research in which the institutional
review board finds that more than minimal risk to children is presented by an interven-
tion or procedure that holds out the prospect of direct benefit for the individual subject
or by a monitoring procedure that is likely to contribute to the subject's well-being).
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However, the most ethically troubling problem in the field of
fetal research is the injustice done to open debate about the ethics
of specific projects by removal of the EAB. The resolution of public
ethical problems requires a proper national forum for debate and
compromise. However, today no national forum for specific
projects exists.
"To force into impotence" aptly describes the result of a 1975
ban on use of federal funds for research with the human pre-em-
bryo.9 ° The NIH, the nation's premier biomedical research agency,
is impotent to provide peer review and funding of research affecting
infertility, human genetics, cancer, and AIDS. Although at least
5000 children have been born after in vitro fertilization (IVF),91 the
NIH has not been able to contribute in any direct way to improving
the science or efficacy of this technique. There is a major need for
research to improve the generally poor results of in vitro fertiliza-
tion and other infertility treatments and to reduce their very large
costs. Infertility affects 2.4 million married couples of reproductive
age and an unknown number of potential parents among unmarried
adults in the United States.92 However, this need remains unmet
due to the ban on the use of federal funds to support these
activities.
"To put down . . .by authority" best describes a moratorium
first imposed in May 1988 by the Assistant Secretary for Health on
any research funded by the Public Health Service using fetal tissue
obtained after elective abortion for transplantation into human be-
ings. 3 In November 1989, the moratorium became a ban94 by or-
der of the HHS Secretary that overrode the December 1988
recommendations of an expert advisory panel convened by the
NIH.95
The laws of the individual states are radically different from
90. See 45 C.F.R. § 46.208 (1990).
91. OFFICE OF TECHNOLOGY ASSESSMENT, U.S. CONGRESS, OTA-BA-358, INFERTIL-
rry: MEDICAL AND SOCIAL CHOICES 293 (1988).
92. Id. at 3.
93. See 45 C.F.R. § 46.210 (1990) (stating "[a]ctivities involving the dead fetus, mas-
cerated fetal material, or cells, tissue, or organs excised from a dead fetus shall be con-
ducted only in accordance with any applicable State or local laws regarding such
activities.").
94. MEMORANDUM FROM THE ASSISTANT SECRETARY FOR HEALTH TO THE DIRECTOR,
NIH, REPORT OF THE HUMAN FETAL TISSUE TRANSPLANTATION RESEARCH PANEL ESTAB-
LISHING TEMPORARY MORATORIUM ON USE OF HUMAN FETAL TISSUE IN TRANSPLANTATION
RESEARCH (1988).
95. REPORT OF THE ADVISORY COMMITTEE TO THE DIRECTOR, NATIONAL INSTITUTES OF
HEALTH, HUMAN FETAL TISSUE TRANSPLANTATION RESEARCH (1988).
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those of the federal government. All fifty states adopted the Uni-
form Anatomical Gift Act in the 1970s, permitting research involv-
ing the abortus with the consent of the parent(s).9 Subsequently,
five states prohibited research with the dead abortus after induced
abortion, except research involving pathological examinations or
97autopsies.
Huge moral contradictions exist in United States research pol-
icy. Investigators in federally supported studies are permitted to
take more than minimal research risks with living children with can-
cer. In fact, in Phase I cancer trials, researchers can give an agent
that is toxic and will, in some cases, lead to the death of the child
before a cancer-induced death. However, researchers are not per-
mitted to touch a human embryo ex utero with intent to do research
to find out how cancer begins. Some cancers begin in the embryo.
How will we ever understand how to treat cancer unless we know
how it begins? They also may not subject a first trimester fetus
which is to be aborted to any research risks they would not also un-
dertake with the fetus to be delivered.9 s
These issues in research ethics affect the ethical climate of every
health care institution with the capacity to do fetal, embryo, and fe-
tal tissue transplant research. Members of ethics committees should
discuss this situation and their responsibilities towards scientists in
the institution and in the federal sector.
D. Restoration of a National Forum for Bioethical Issues
There has been no successor to the national bioethics bodies of
the 1970s and early 1980s. The Congressional Biomedical Ethics
Board (CBEB), authorized by Congress in 198599 and constituted in
1988, collapsed in 1989 under the weight of abortion controversy
before being able to begin its public work.'0° The CBEB's three
mandates were to prepare reports for Congress on human genetic
engineering, to review regulations governing fetal research and the
96. See, e.g., CAL. HEALTH & SAFETY CODE §§ 7150-7158 (West 1970) (providing that
a decedent may donate his body, and including a stillborn infant or fetus within the
definition of "decedent").
97. These states are Arizona, Illinois, Indiana, Ohio, and Oklahoma. However, the
Illinois law permits experimental transplantation with tissue of spontaneously aborted
fetuses.
98. See supra at nn.93-95 and accompanying text.
99. See Health Research Extension Act of 1985, Pub. L. No. 99-158, 99 Stat. 820
(1985).
100. Cook-Deegan, Abortion Politics Deals Death Blow to Bioethics Body Set Up by Congress, 4
KENNEDY INSTITUTE OF ETHICS NEWSLETrER 4, 5 (1990).
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role of the Secretarial waiver for projects involving more than mini-
mal risks, and to review regulations on the feeding and hydration of
dying patients.' 0 ' However, the short-lived CBEB should not be
mistaken as an intended replacement for the EAB. The EAB was
supposed to recommend ethically controversial scientific guidelines
for research to the Secretary of HHS and to advise him on research
policy matters.'0 2 The CBEB would have advised Congress only on
ethical and scientific standards to govern fetal research and other
problems as mandated by Congress. 10 3
Recently, the American College of Obstetricians and Gynecolo-
gists and the American Fertility Society moved to establish a na-
tional ethics advisory board to monitor fetal tissue transplant
research and embryo research.' ° This plan by scientific leaders
whose research is most affected by the separation of federal and pri-
vate support is similar to an arrangement (Voluntary Licensing Au-
thority) that prevailed in the United Kingdom after the government
took no immediate steps to implement the findings of the Warnock
Report that approved limited research involving human embryos.10 5
In a democracy such as ours, a national body is needed to pro-
vide an open forum for debate and recommendations on the issues
originally referred to the CBEB. Such a forum also provides a place
to discuss and formulate plans of action on the critical and timely
issue of access to health care. The absence of such a national body
is causing great harm to the country. Nothing less than restoration
of a national body will suffice, although great care must be taken to
minimize political manipulation of this body. Although political ac-
tion to stimulate the desire for change will be necessary, local hospi-
tal ethics committees and institutional review boards must voice
their needs for clearer national guidelines.
CONCLUSION
In this article, I do not dispute Susan Wolf's argument for due
process and protection of patients' rights within ethics committees.
My approach to the issue, though, differs from hers. Rather than
focusing on the schizophrenia that tends to burden committees' ac-
101. See id.
102. See 45 C.F.R. § 46.204 (1990).
103. See id.
104. See Groups Plan Advisory Board for Fetal Tissue Research, Wash. Post, Jan. 8, 1991, at
A3.
105. THE ILA SECRETARIAT, IVF RESEARCH IN THE U.S. [Report published by The In-
terim Licensing Authority, 20 Park Crescent, London, WIN 4AL, United Kingdom].
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tivities today, I place the committee in a historical and evolutionary
perspective. Ethics committees are in the process of evolution, and
the issues they address are features on the social and political land-
scape of bioethics. These issues will affect the evolution of commit-
tees, just as the committee decisions will reshape the issues. To use
Wolf's nesting rights metaphor, I want to understand the tree that
the nest will be built in-the better to build the nest and attach it
firmly to the tree.
Above, I propose both a national bioethics agenda for the
1990s and a programmatic approach for individual ethics commit-
tees and their institutions. The two are inseparably linked by a com-
mitment to raise awareness of the role of bioethics in medicine
within the medical, lay, and political communities. My stress on
such broad educational efforts within the community and with clini-
cians is particularly responsive to Wolf's agrument for due process
within the ethics committee. It suggests that many of the difficult
cases committees confront can be effectively addressed in their early
stages by increased sensitivity to bioethical dilemmas in patient care.
The programmatic approach attempts to treat the cause of the schiz-
ophrenia within committees rather than responding to symptoms.
In an institutional ethics program with strong bonds with the
community, clinicians will better know how and when to ask for bed-
side consultation that is more effective and engaging than a full
committee proceeding. The committee, by restricting, not only can
minimize legalistic confrontations between patients and clinicians,
but also can free resources for the tasks of educating the community
and preparing clinicians better to identify and respond to ethical
problems in patient care.
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APPENDIX A
University of Virginia Health Sciences Center Ethics Consultation Policy
February 9, 1990
Primary responsibility for identifying and resolving ethical
problems in the clinical setting (conflicts of values, principles, or in-
terests) rests with the professional staff in concert with patients, and,
where appropriate, their families or other representatives. The Eth-
ics Committee of the Health Sciences Center provides assistance
with ethical problems pertaining to patient care through its interdis-
ciplinary Ethics Consultation Service (ECS) which is available on a
24-hour basis to hospital staff, patients, and patients' families or
other representatives.
Health Sciences Center staff are encouraged to seek timely in-
volvement of the ECS in ethically troublesome situations. The
Health Sciences Center assures that persons requesting ethics con-
sultation may do so without intimidation or fear of reprisal.
Ethics consultation seeks to facilitate communication and
shared decisionmaking in patient care; to foster greater awareness
among health professionals of the relationship of values (their own
and their patients') to health care decisionmaking; to prevent harm
to patients, health professionals, and the institution; and to teach
health professionals to recognize and resolve ethical problems. The
recommendations of ethics consultants are advisory only. The pro-
cess of ethics consultation is intended to supplement and support-
not supplant--existing departmental and institutional mechanisms
for making decisions and resolving conflicts in clinical practice.
Procedure
1. The ECS is a service of the Ethics Committee and reports
directly to it. The ECS helps those persons directly involved in a
patient's care to identify, analyze, and resolve ethical problems per-
taining to the care of that patient. Clinicians are particularly en-
couraged to seek assistance from the ECS when:
a. the best efforts of the health care providers to resolve an eth-
ical problem have reached an impasse;
b. the ethical problem involves a serious disagreement or dis-
pute among the health care providers;
c. the case is unusual, unprecedented, or very complex
ethically;




2. Requests for ethics consultation may be made by health care
providers, patients, family members or guardians, students, or
others with a legitimate interest in the patient.
3. Requests for ethics consultation are made by calling the eth-
ics consultant on-call (consultants are available 24 hours a day).
4. The ECS adheres to the following protocol in a formal
consultation:
a. The attending physician will be informed that a request for
consultation has been made and he/she will have an oppor-
tunity to discuss the situation with the primary ethics
consultant.
b. The patient and/or family (if the patient is incapacitated) will
be informed that a consultation has been requested and will
be encouraged to participate.
c. The charge nurse will be informed of the time and place of
the consultation.
d. The primary consultant will place a summary of the consul-
tation and any recommendations in the patient's chart. This
note will be countersigned by the ECS director or his desig-
nated alternate.
e. If the ECS team is unable to resolve the problems in a partic-
ular case, the chairman of the Ethics Committee will be so
notified and may then convene an ad hoc group, as outlined
below, to assist in achieving resolution.
(1) Upon referral of a case, the chairman of the Ethics Com-
mittee may choose to appoint an ad hoc group of at least
five persons to review and discuss the case further.
(2) This committee, selected by the chairman of the Ethics
Committee or his designated alternate, shall include the
following members: a physician, who shall chair the
group; a nurse; and three or more members selected
from among an ethicist, a member of the clergy, a law-
yer, a hospital administrator, another member of the
clinical staff, and a community representative. Commit-
tee members may but do not have to be members of the
Ethics Committee. This committee may at any time ask
the chairman of the Ethics Committee to appoint to it
additional members (e.g., persons with special skills or
knowledge).
(3) The committee shall be available on a 24-hour basis for
prompt meetings about the case in question.
(4) If the committee convenes meetings, it shall conduct at
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least one meeting which is open to the patient and/or
the patient's family (or appropriate representative) and
the physicians, nurses, and other health care providers
involved in the case. Except as provided in this policy,
the committee may decide for itself all procedural ques-
tions pertinent to the meetings about the case.
(5) In meetings about the case, the chairman of the commit-
tee shall ask one member to serve as special advocate for
the patient.
(6) The committee shall help ensure that the patient and the
family or appropriate representative have been fully in-
formed of the patient's condition, prognosis, and treat-
ment options, and that all parties have been appraised of
all appropriate available health care and support
services.
5. The ECS is also available for consultation on ethical
problems related to clinical research (a) prior to the submission of
research proposals to the Human Investigation Committee or (b)
after approved research has begun.
6. There shall be no charges, billing, or fees for service for eth-
ics consultation.
7. The ECS is not intended or authorized to provide legal ad-
vice on patient care. Legal questions and concerns regarding
patient care should be referred to the University General Counsel




Developing Hospital Ethics Programs in Virginia
"Developing Hospital Ethics Programs" (DHEP) is a statewide
outreach program of the Center for Biomedical Ethics at the Univer-
sity of Virginia (U.Va. Center). It is designed to assist hospitals in
identifying their specific needs with regard to strengthening or start-
ing an ethics program, and in educating and training two appointed
resource persons, who will become fellows of the U.Va. Center in a
work-study program that will result in a plan for on-going support
for the hospital from DHEP. During 1990-92, the program involves
20 hospitals, 10 in each full calendar year. What follows is a phase-
by-phase program plan.' 0 6
Project Phases
Phase I (Januay 1990-June 1990).-The first phase is designed to
assist each hospital with a needs assessment to evaluate its readiness
for an ethics program and to rank priorities among the features of
the program.
Phase II (July 1990-March 1991).-In July, the hospital's chief
executive officer (CEO) and the hospital ethics committee will iden-
tify and appoint two resource persons (twenty total). Upon their
appointment, these persons will become Virginia fellows and come
weekly for thirteen weeks, starting in September 1990, for education
and training to respond to the needs and priorities of the sponsor-
ing institution by developing a DHEP plan. By March 15, 1991, a
mid-way evaluation of the strengths and weaknesses of a proposed
DHEP plan will be completed by the local hospital ethics committee
and hospital CEO.
Phase Ii (April 1991-December 1991).-The twenty fellows, as-
sisted by U.Va. Center staff and working with their home hospital
ethics committees, will implement the first stage of a DHEP plan,
including an evaluation component to be completed by December
1991.
Phase IV (by March 15, 1992).-The U.Va. Center's DHEP pro-
ject will be evaluated by local assessment of the first stage of a
106. As the dates indicate, the DHEP program is well under way. However, in order
to preserve the essential forward-looking character of a "plan" this Appendix adopts the
future tense of the original.
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DHEP plan for that hospital, plus telephone or personal interviews
with the twenty fellows, hospital ethics committee chairpersons, and
U.Va. Center staff. The evaluation will be done by an independent
evaluator in the humanities to be selected. A written report will be
prepared by the evaluator.
Project Activities
Phase .- The goal of this phase is an assessment, in a par-
ticipatory process, of the hospital's readiness to support the evolu-
tion of a full ethics program. A simple five-part needs assessment
will be given to all health care professionals in each hospital. Each
hospital will receive a research report that will rank the ethical
problems (as seen by different professionals) that most need atten-
tion, as well as the needs of professionals and the hospital for a
forum to raise issues, for education in ethics and health law, for eth-
ics consultation, and for guidelines on ethically important policy is-
sues. This phase ends with a ranking of priorities for development
of the local hospital ethics program.
Phase H.-Two appointed persons will come to the U.Va.
Center as Virginia fellows, supervised by the Coordinator for Out-
reach Programs who will be assisted by other faculty in four areas of
expertise most required in clinical ethics and ethics consults:
biomedical ethics, health care law, clinical knowledge, and interper-
sonal skills.
In Phase II, the visiting fellows will engage in three activities.
First, they will take a basic clinical ethics and health care law course.
Second, they will complete an initial thirteen session cycle of a Vir-
ginia fellows seminar on "Hospital Ethics Programs" designed to
cover what is known about the five elements of a program and to
focus on their institutions. The seminar will be the major resource
for developing a DHEP plan with an evaluation component. 0 7 And
third, they will observe the U.Va. hospital ethics program, its hospi-
107. Topics for the hospital ethics program seminar include:
September 1990: Four overview sessions on hospital ethics committees, educa-
tion in clinical ethics and health law, ethics consultation, and the biomedi-
cal ethics resource person;
October 1990: The same four sessions repeated in the context of their hospi-
tals using needs assessment and priorities data;
November 1990: Four sessions to develop DHEP plans in four areas, plus a
tentative design for evaluation;




tal ethics committee and ethics consultation service classes, and ac-
tivities in the U.Va. Health Sciences Center relating to biomedical
ethics and health law.
During this period, a member of the Educational Team will
make one site visit to a participating hospital. The purpose of the
visit will be to coordinate a meeting of the hospital ethics committee
and the resource persons and to help them to compose the first
draft of a DHEP.
The fellows will work together in pairs, with the help of the
seminar leaders, to develop a DHEP plan for their hospital. The
plan will be evaluated for strengths and weaknesses by the local hos-
pital ethics committee and the hospital CEO by March 15, 1991.
Phase II.-After the mid-way evaluation, each pair of fellows
will begin to implement the DHEP plan. They will return to the
U.Va. Center for eight weekly seminars in April and May, 1991 to
complete their seminar studies of hospital ethics programs and to
report on problems and progress to date. The content of the last
cycle of seminars must not be planned prematurely.
During the summer of 1991, U.Va. Center staff will conduct a
final site visit to assist the hospital ethics committee and resource
persons with the plan, as well as in planning for future components
of their program.
The hospital CEO and the chair of the hospital ethics commit-
tee, along with the two fellows, will be invited to the U.Va. Center
for a two-day conference in November 1991 to report on the pro-
gress of their ethics programs. At this time, a full picture of pro-
gress to date should emerge.
Phase IV.-Final project evaluation will take place.
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